Carasent AB (publ) (STO:CARA)
Sweden · Delayed Price · Currency is SEK 23.70
-0.20 (-0.84%)
Feb 10, 2026, 5:29 PM CET
Carasent AB Market Cap
Carasent AB has a market cap or net worth of 1.67 billion as of February 10, 2026. Its market cap has increased by 5.29% in one year.
Market Cap
1.67B
Enterprise Value
1.53B
Revenue
328.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.70
Market Cap Chart
Since December 12, 2012, Carasent AB's market cap has increased from 48.86M to 1.67B, an increase of 3,321.28%. That is a compound annual growth rate of 30.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 1.67B | -12.93% |
| Dec 30, 2025 | 1.92B | 19.57% |
| Dec 30, 2024 | 1.61B | 3,186.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.81B |
| Getinge AB | 55.51B |
| Camurus AB | 40.94B |
| Sectra AB | 40.19B |
| Humana AB | 2.10B |
| Egetis Therapeutics AB | 1.97B |
| EQL Pharma AB | 1.82B |
| Devyser Diagnostics AB | 1.81B |